CMS provided updated coding and billing information in its Clinical Laboratory Fee Schedule (CLFS) for organizations performing tests for COVID-19 and providing treatment for confirmed or suspected COVID-19 infections.
National Correct Coding Initiative (NCCI) edits can be a major stumbling block in the billing process. Take a look at the different types of NCCI edits and strategies to address them.
This week’s Medicare updates include an article on elements necessary to include on orders or prescriptions for certain DMEPOS items, an NCA on colorectal cancer blood-based biomarker tests, a change to the Medicare Physician Fee Schedule database update file, and more!
Like other services covered by Medicare, observation must be reasonable and necessary or, in other words, medically necessary. The physician must document that they assessed patient risk to determine that the patient would benefit from observation services.
The Centers for Disease Control and Prevention (CDC) is monitoring the rapid spread of a novel 2019 coronavirus, formally named COVID-19, first identified in Wuhan, Hubei Province, China. On January 30, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern due to its sustained person-to-person spread within countries and across continental borders.
